ProApolipoprotein A1

N. Marchi,P. Mazzone,V. Fazio,T. Mekhail,T. Masaryk,D. Janigro
DOI: https://doi.org/10.1002/cncr.23314
IF: 6.9209
2008-03-15
Cancer
Abstract:Central nervous system (CNS) diagnostics is a promising tool for detection of neurological disorders, including brain metastases. One of the earliest applications of CNS diagnostics was based on serum markers of blood‐brain barrier (BBB) dysfunction, which often correlates with acute, chronic, or incipient brain disease. In the case of brain metastases, serum levels of S100β demonstrated a good negative predictive value comparable to radiologic investigations. However, a confounding factor was the presence of BBB changes due to cerebrovascular disease.
What problem does this paper attempt to address?